Primary Care Physicians' Knowledge of Cochlear Implantation
Edward Wu, BS (presenter); Shawn Zardouz; Vanessa Rothholtz, MSc, MD; Michael German, MD; Hamid Djalilian, MD OBJECTIVE: To assess the baseline knowledge of Southern California primary care physicians (PCPs) regarding hearing loss and cochlear implantation with the aim of determining the ideal mechanism for educating PCPs on this topic. METHOD: Southern California PCPs were surveyed via mail or in person (Grand Rounds, regional meetings, clinics). The survey assessed knowledge of risk factors of congenital hearing loss; cochlear implantation as a treatment option for children, including diagnosis, indications, and impact; and mechanisms by which PCPs prefer to be educated on cochlear implantation. One hundred and forty-eight surveys were included in the analysis. RESULTS: Most (93.9%) of PCPs are familiar with cochlear implantation. On questions related to the knowledge of risk factors for congenital hearing loss, familiarity ranged from 30-90%. Sixty to 90% of PCPs were knowledgeable about the signs of hearing loss and developmental milestones in children.
On topics related to cochlear implantation, only 67% of PCPs knew that cochlear implantation restores hearing for deaf individuals and 70% were not aware of the vaccination guidelines for cochlear implant patients. The most favored mechanism of learning about cochlear implants was through continued medical education (CME) events (61.0%). CONCLUSION: A sizeable portion of Southern California PCPs are not knowledgeable about congenital hearing loss and cochlear implantation. Further education and the continued close relationship between neurotologists and PCPs are necessary to deliver the most optimal care for children with hearing loss.
Prognosis of Hearing Loss with Vogt-Koyanagi-Harada Disease
Norihito Takeichi, MD, PhD (presenter); Keishi Fujiwara, MD; Shigeru Akazawa, MD; Satoshi Fukuda, MD, PhD OBJECTIVE: Vogt-Koyanagi-Harada disease (VKH disease) has been described as an autoimmune disease which targets melanocytes. Although VKH disease patients often report tinnitus and hearing loss, small number of the study have been reported about their hearing function. METHOD: We have investigated the hearing level of 64 patients to obtain the accurate information of their hearing abilities. Fifty two percent of the patients were diagnosed as having sensory neural hearing loss (Ͼ25dB). 81% of all the cases showed the increase of hearing levels at 10dB or more by steroid medication. We compared hearing improvement group (40 ears) and the hearing ability immutability group (22 ears) about presence of the mean hearing ability, age, symptom, tinnitus, dizziness and nystagmus at initial diagnosis to examine the prognosis factor. RESULTS: Of these, we showed a significant difference by a t-test only with mean hearing ability at initial diagnosis (pϽ0.05). In general, hearing loss with VKH disease has been known to have a good prognosis. Since the hearing loss is usually mild and occurs in bilateral, it is difficult to tell the difference from the aging. CONCLUSION: Particularly for cases in which there are no symptoms, and when mean hearing level is less than 25dB, differentiation with age-related sensorineural hearing loss is necessary. Every patient with VKH disease should be carefully observed not only for eye function but also for hearing.
Programmed Cell Death in the Developing Inner Ear
Hisaki Fukushima, MD (presenter); Norimasa Morita, MD, PhD; Tamotsu Harada, MD, PhD OBJECTIVE: We previously revealed that there was autophagic cell death as the TUNEL-positive cell death other than apoptosis using the mouse embryonic inner ear. We also found
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